Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation

M. A. Gianfrancesco, L. Balzer, K. E. Taylor, L. Trupin, J. Nititham, Michael F Seldin, A. W. Singer, L. A. Criswell, L. F. Barcellos

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


Systemic lupus erythematous (SLE) is a chronic autoimmune disease associated with genetic and environmental risk factors. However, the extent to which genetic risk is causally associated with disease activity is unknown. We utilized longitudinal-targeted maximum likelihood estimation to estimate the causal association between a genetic risk score (GRS) comprising 41 established SLE variants and clinically important disease activity as measured by the validated Systemic Lupus Activity Questionnaire (SLAQ) in a multiethnic cohort of 942 individuals with SLE. We did not find evidence of a clinically important SLAQ score difference (>4.0) for individuals with a high GRS compared with those with a low GRS across nine time points after controlling for sex, ancestry, renal status, dialysis, disease duration, treatment, depression, smoking and education, as well as time-dependent confounding of missing visits. Individual single-nucleotide polymorphism (SNP) analyses revealed that 12 of the 41 variants were significantly associated with clinically relevant changes in SLAQ scores across time points eight and nine after controlling for multiple testing. Results based on sophisticated causal modeling of longitudinal data in a large patient cohort suggest that individual SLE risk variants may influence disease activity over time. Our findings also emphasize a role for other biological or environmental factors.

Original languageEnglish (US)
Pages (from-to)358-362
Number of pages5
JournalGenes and Immunity
Issue number6
StatePublished - Sep 1 2016

ASJC Scopus subject areas

  • Immunology
  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'Genetic risk and longitudinal disease activity in systemic lupus erythematosus using targeted maximum likelihood estimation'. Together they form a unique fingerprint.

Cite this